stockportfolio.pro
Medline Inc. (MDLN)
Healthcare · Medical Instruments & Supplies · NasdaqGS
Medline Inc. revenue & earnings — last 4 fiscal years
| Metric | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|
| Revenue | $23.23B | $25.51B | $0 | $28.43B |
| Gross profit | $5.88B | $6.98B | — | $7.52B |
| Net income | $234.00M | $1.16B | $1.15B | $1.16B |
| Net margin | 1.0% | 4.6% | — | 4.1% |
Source: Medline Inc. SEC filings (10-K).
What growth is priced into MDLN stock?
At today's market cap of $64.50B, Medline Inc. is priced for free-cash-flow growth of about 20.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.30B from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Medline Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track MDLN in your portfolio →
Medline Inc. financial history by metric
About Medline Inc.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.
Medline Inc. — frequently asked questions
What is Medline Inc.'s revenue?
Medline Inc. (MDLN) reported revenue of $28.43B for fiscal year 2025, according to its SEC filings.
Is Medline Inc. profitable?
Yes. MDLN earned net income of $1.16B in fiscal 2025, a net margin of 4.1%.
What is MDLN's P/E ratio?
Medline Inc. trades at a price-to-earnings ratio of about 31.8 based on the latest data in our nightly-refreshed cache.
How fast is Medline Inc. growing?
MDLN's revenue grew at roughly 7.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Medline Inc. have?
As of fiscal year 2025, MDLN carried roughly $12.56B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Medline Inc.'s gross margin?
MDLN's gross margin was 26.4% in fiscal 2025 — gross profit of $7.52B on revenue of $28.43B.
What is Medline Inc.'s market cap?
Medline Inc. (MDLN) has a market capitalization of about $64.50B, based on the latest data in our nightly-refreshed cache.
When does Medline Inc.'s fiscal year end?
MDLN's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into MDLN stock?
At today's market cap of $64.50B, Medline Inc. is priced for free-cash-flow growth of about 20.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.30B from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Medline Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.